Luspatercept as a therapy for myelodysplastic syndromes with ring sideroblasts
Sign Up to like & getrecommendations! Published in 2021 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2021.1947791
Abstract: ABSTRACT Introduction Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic stem cell diseases characterized by cell dysplasia, ineffective hematopoiesis and risk of transformation to acute myeloid leukemia (AML). The median age of 75 years… read more here.
Keywords: syndromes ring; myelodysplastic syndromes; ring sideroblasts; therapy myelodysplastic ... See more keywords